PMID: 12223492

Loo TW, Clarke DM
Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein.
J Biol Chem. 2002 Nov 15;277(46):44332-8. Epub 2002 Sep 9., 2002-11-15 [PubMed]
Sentences
No. Mutations Sentence Comment
130 ABCB1 p.Met68Cys
X
ABCB1 p.Met68Cys 12223492:130:16
status: NEW
view ABCB1 p.Met68Cys details
ABCB1 p.Leu65Cys
X
ABCB1 p.Leu65Cys 12223492:130:67
status: NEW
view ABCB1 p.Leu65Cys details
The activity of M68C, was inhibited by 44%, whereas that of mutant L65C was increased (189%). Login to comment
131 ABCB1 p.Tyr118Cys
X
ABCB1 p.Tyr118Cys 12223492:131:14
status: NEW
view ABCB1 p.Tyr118Cys details
ABCB1 p.Val125Cys
X
ABCB1 p.Val125Cys 12223492:131:21
status: NEW
view ABCB1 p.Val125Cys details
Four mutants (Y118C, V125C, V133C, and C137) in TM2 were very sensitive to MTS-rhodamine because they were inhibited 94, 68, 80, and 93%, respectively. Login to comment
132 ABCB1 p.Gln132Cys
X
ABCB1 p.Gln132Cys 12223492:132:7
status: NEW
view ABCB1 p.Gln132Cys details
Mutant Q132C showed weaker inhibition (32%). Login to comment
133 ABCB1 p.Gln195Cys
X
ABCB1 p.Gln195Cys 12223492:133:49
status: NEW
view ABCB1 p.Gln195Cys details
ABCB1 p.Lys189Cys
X
ABCB1 p.Lys189Cys 12223492:133:39
status: NEW
view ABCB1 p.Lys189Cys details
In TM3, the activities of two mutants (K189C and Q195C) were inhibited 76 and 78%, respectively, by MTS-rhodamine. Login to comment
138 ABCB1 p.Asn296Cys
X
ABCB1 p.Asn296Cys 12223492:138:27
status: NEW
view ABCB1 p.Asn296Cys details
ABCB1 p.Phe314Cys
X
ABCB1 p.Phe314Cys 12223492:138:52
status: NEW
view ABCB1 p.Phe314Cys details
In contrast, four mutants (N296C, G300C, Y310C, and F314C) were inhibited by Ͼ70% with MTS-rhodamine. Login to comment
139 ABCB1 p.Ile340Cys
X
ABCB1 p.Ile340Cys 12223492:139:31
status: NEW
view ABCB1 p.Ile340Cys details
ABCB1 p.Ala342Cys
X
ABCB1 p.Ala342Cys 12223492:139:41
status: NEW
view ABCB1 p.Ala342Cys details
The activities of two mutants (I340C and A342C) in TM6 were strongly inhibited (87 and 94%, respectively) by MTS-rhodamine. Login to comment
140 ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:140:23
status: NEW
view ABCB1 p.Phe343Cys details
The activity of mutant F343C, however, was increased (347%) after treatment with MTS-rhodamine. Login to comment
155 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 12223492:155:68
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Ile340Cys
X
ABCB1 p.Ile340Cys 12223492:155:54
status: NEW
view ABCB1 p.Ile340Cys details
ABCB1 p.Ala841Cys
X
ABCB1 p.Ala841Cys 12223492:155:61
status: NEW
view ABCB1 p.Ala841Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 12223492:155:79
status: NEW
view ABCB1 p.Val982Cys details
Lower levels of protection were observed with mutants I340C, A841C, L975C, and V982C (Fig. 5). Login to comment
164 ABCB1 p.Leu65Cys
X
ABCB1 p.Leu65Cys 12223492:164:13
status: NEW
view ABCB1 p.Leu65Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:164:22
status: NEW
view ABCB1 p.Phe343Cys details
Two mutants, L65C and F343C, showed increased activity after treatment with MTS-rhodamine. Login to comment
165 ABCB1 p.Leu65Cys
X
ABCB1 p.Leu65Cys 12223492:165:15
status: NEW
view ABCB1 p.Leu65Cys details
Because mutant L65C had only 51% of the verapamil-stimulated ATPase activity relative to that of the Cys-less parent (22), treatment with MTS treatment essentially restored the activity of the mutant to that of the Cys-less P-gp. Login to comment
167 ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:167:7
status: NEW
view ABCB1 p.Phe343Cys details
Mutant F343C showed about 3.5-fold increase in activity after treatment with MTS-rhodamine. Login to comment
168 ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 12223492:168:15
status: NEW
view ABCB1 p.Phe343Cys details
Because mutant F343C had about 60% of the activity of Cys-less P-gp, reaction with MTS-rhodamine essentially causes a 2-fold increase in activity relative to the Cys-less parent. Login to comment
172 ABCB1 p.Val52Cys
X
ABCB1 p.Val52Cys 12223492:172:24
status: NEW
view ABCB1 p.Val52Cys details
ABCB1 p.Gly62Cys
X
ABCB1 p.Gly62Cys 12223492:172:40
status: NEW
view ABCB1 p.Gly62Cys details
Three cysteine mutants (V52C, G54C, and G62C) in TM1 were not tested because of low expression, indicating that these residues must be important for structure and/or function. Login to comment
186 ABCB1 p.Asn839Ile
X
ABCB1 p.Asn839Ile 12223492:186:28
status: NEW
view ABCB1 p.Asn839Ile details
Mutations in TM9 (I837L and N839I) or in TM6 (G388A and A339P) resulted in similar drug resistance profiles with four structurally different drugs (increased resistance to vincristine or actinomycin D but decreased resistance to colchicine or daunorubicin relative to wild-type P-gp). Login to comment